The big short. Bearish bets on biggest tech stocks hit $37 billionThe greater the rise, the greater the fall, so they are being targeted as the stocks to short.
'Indian IP and liabilities law barrier to pharma R&D investment'India's intellectual property regulations and liabilities laws pose a major barrier to foreign companies, specially from the US, that preve...
How billionaire father-son duo turned family firm into world beaterLast month Pankaj Patel announced his more than 20-years running the company were over.
Hedge fund revival quickensEvent-driven funds handed investors a return of about 10% last year.
How US hedge fund owners ensured their firms remained among 2014’s best-performing fundsMortgage funds did well in 2014 because home prices rose and fewer debtors missed payments on their loans -- including the subprime borrowe...
Shire Plc flags existing and new drugs in defence to AbbVieThe London-listed drugmaker is seeking to convince shareholders that a $46 billion takeover offer from US group AbbVie undervalues the busi...